- Home
- CRDF vs ALLT Comparison
CRDF vs ALLT Comparison
Compare CRDF & ALLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- ALLT
- Stock Information
- Founded
- CRDF 1999
- ALLT 1996
- Country
- CRDF United States
- ALLT Israel
- Employees
- CRDF N/A
- ALLT N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- ALLT Telecommunications Equipment
- Sector
- CRDF Health Care
- ALLT Telecommunications
- Exchange
- CRDF Nasdaq
- ALLT Nasdaq
- Market Cap
- CRDF 133.5M
- ALLT 149.3M
- IPO Year
- CRDF N/A
- ALLT 2006
- Fundamental
- Price
- CRDF $4.96
- ALLT $5.05
- Analyst Decision
- CRDF Strong Buy
- ALLT Buy
- Analyst Count
- CRDF 3
- ALLT 1
- Target Price
- CRDF $10.33
- ALLT $13.00
- AVG Volume (30 Days)
- CRDF 3.9M
- ALLT 609.5K
- Earning Date
- CRDF 11-07-2024
- ALLT 02-13-2025
- Dividend Yield
- CRDF N/A
- ALLT N/A
- EPS Growth
- CRDF N/A
- ALLT N/A
- EPS
- CRDF N/A
- ALLT N/A
- Revenue
- CRDF $688,000.00
- ALLT $91,631,000.00
- Revenue This Year
- CRDF $23.78
- ALLT $0.41
- Revenue Next Year
- CRDF N/A
- ALLT $8.84
- P/E Ratio
- CRDF N/A
- ALLT N/A
- Revenue Growth
- CRDF 49.57
- ALLT N/A
- 52 Week Low
- CRDF $1.30
- ALLT $1.40
- 52 Week High
- CRDF $6.42
- ALLT $5.50
- Technical
- Relative Strength Index (RSI)
- CRDF 72.82
- ALLT 64.78
- Support Level
- CRDF $3.06
- ALLT $4.84
- Resistance Level
- CRDF $5.64
- ALLT $5.45
- Average True Range (ATR)
- CRDF 0.45
- ALLT 0.32
- MACD
- CRDF 0.29
- ALLT -0.01
- Stochastic Oscillator
- CRDF 84.32
- ALLT 57.30
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.